<DOC>
	<DOCNO>NCT01967550</DOCNO>
	<brief_summary>This study evaluate efficacy safety diclofenac DDEA 2.32 % patient suffering knee osteoarthritis ( OA ) .</brief_summary>
	<brief_title>Efficacy Safety Diclofenac DDEA 2.32 % Patient Suffering From Knee Osteoarthritis ( OA )</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>1 . Male female ≥ 50 year old ; 2 . Symptomatic OA one knee , accord ACR criterion , diagnose least 6 month previously ; 3 . Pain either knee originates knee ( refer pain site , hip back ) cause pain knee OA ; 4 . Have use oral NSAIDs COXIBs knee OA pain ( include aspirin ≥ 500 mg use indication ) , least one dose per day , less 10 day 14 day precede screen visit also within 24 hour precede screen visit ; 5 . Be able tolerate rescue medication 500 mg paracetamol ( APAP ) take dose 12 tablet maximum 6 tablet ( 3 gram ) per day duration study 1 . Partial total replacement either knee joint , past planned/expected study duration . 2 . OA knee due underlying condition , gout , chondrocalcinosis , hemochromatosis , joint infection , neuropathia , severe traumatic joint damage ( however , common risk factor , obesity past meniscectomy ligament rupture repair , allow ) ; 3 . History systemic inflammatory ( autoimmune ) disease ( rheumatoid arthritis , systemic psoriasis , systemic lupus erythematosus , systemic sclerosis , etc . ) laboratory value indicative disease subsequent diagnosis physician ; 4 . Fibromyalgia within previous year ; 5 . Allergy asthma diclofenac , APAP , aspirin , NSAIDs ingredient gel ( i.e . isopropyl alcohol , propylene glycol , butylhydroxytoluene ) , contraindication study drug rescue medication</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Symptomatic knee OA Kellgren-Lawrence grade 1-3</keyword>
</DOC>